Mutagenesis and disease progression in RUNX1 mutant blood stem cells is caused by inflammation-induced hyperactive signaling and supraphysiological mitochondrial ROS |
St. Jude Children’s Research Hospital / Dirk Loeffler, PhD |
RUNX1 Early Career Investigator Grants |
2023 |
Tennessee |
Ex Vivo Modeling of Medulloblastoma using Human iPSC-Derived Cerebellar Organoids |
St. Jude Children’s Research Hospital / Stephanie Wu, PhD |
Young Investigator Grants |
2023 |
Tennessee |
Synthetic gene expression regulator switches (SynGERS) expressed in CAR T cells to cure children with solid tumors |
Baylor College of Medicine / Andras Heczey, MD |
R Accelerated Award Grants |
2023 |
Texas |
Structure-guided de novo design of molecules that selectively target EWS-FLI1 |
University of Texas Health Science Center at San Antonio / David Libich, PhD |
Innovation Grants |
2023 |
Texas |
Synthetic Gene Expression Regulatory Switches (SynGERS) for Improved CAR T Cell Function in Pediatric Solid Tumors |
Baylor College of Medicine / Leidy Diana Caraballo Galva, PhD |
Young Investigator Grants |
2023 |
Texas |
Development of New Approaches to Target MAP Kinase Pathway in RAS-driven Rhabdomyosarcoma |
University of Texas Health Science Center at San Antonio / Angelina Vaseva, PhD |
R Accelerated Award Grants |
2023 |
Texas |
In Situ CD19.CAR-T Generation Using TRIDENT System for Pediatric B Cell Malignancies |
Baylor College of Medicine / Masataka Suzuki, PhD |
Innovation Grants |
2023 |
Texas |
Ectopic Neuroligin Signaling in Pediatric Glioblastoma |
University of Utah / Alex Shcheglovitov, PhD |
Innovation Grants |
2023 |
Utah |